Estimates Revisions LifeMD, Inc. Nasdaq
Stocks
LFMDP
US53216B2034
Advanced Medical Equipment & Technology
|
Delayed
Nasdaq
09:42:13 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 23.40 USD | +0.65% |
|
-0.43% | +6.17% |
| 08-06 | B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating | MT |
| 08-05 | LifeMD, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| - | - | ||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- LFMD Stock
- LFMDP Stock
- Consensus LifeMD, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
